These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 35910347)

  • 1. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.
    Gallez B
    Front Pharmacol; 2022; 13():853568. PubMed ID: 35910347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hypoxia in cancer therapy.
    Wilson WR; Hay MP
    Nat Rev Cancer; 2011 Jun; 11(6):393-410. PubMed ID: 21606941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions.
    Busk M; Overgaard J; Horsman MR
    Semin Nucl Med; 2020 Nov; 50(6):562-583. PubMed ID: 33059825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy.
    Li Y; Zhao L; Li XF
    Front Oncol; 2021; 11():700407. PubMed ID: 34395270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia signaling in cancer: Implications for therapeutic interventions.
    Zhuang Y; Liu K; He Q; Gu X; Jiang C; Wu J
    MedComm (2020); 2023 Feb; 4(1):e203. PubMed ID: 36703877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia: Turning vessels into vassals of cancer immunotolerance.
    Schito L; Rey S
    Cancer Lett; 2020 Sep; 487():74-84. PubMed ID: 32470491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia Stress Response Pathways: Modeling and Targeted Therapy.
    Sridharan S; Varghese R; Venkatraj V; Datta A
    IEEE J Biomed Health Inform; 2017 May; 21(3):875-885. PubMed ID: 28113565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-targeting bacteria in cancer therapy.
    Staedtke V; Sun N; Bai R
    Semin Cancer Biol; 2024 May; 100():39-48. PubMed ID: 38554791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: From 3D modeling to clinical concepts.
    Shahpouri M; Adili-Aghdam MA; Mahmudi H; Jaymand M; Amoozgar Z; Akbari M; Hamblin MR; Jahanban-Esfahlan R
    J Control Release; 2023 Jan; 353():1002-1022. PubMed ID: 36516901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Strategies to Block the Hypoxic Response.
    DiGiacomo JW; Gilkes DM
    Adv Exp Med Biol; 2019; 1136():141-157. PubMed ID: 31201722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-activated nanomedicines for effective cancer therapy.
    Zhou M; Xie Y; Xu S; Xin J; Wang J; Han T; Ting R; Zhang J; An F
    Eur J Med Chem; 2020 Jun; 195():112274. PubMed ID: 32259703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy.
    Baran N; Konopleva M
    Clin Cancer Res; 2017 May; 23(10):2382-2390. PubMed ID: 28137923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemistry and radiochemistry of hypoxia-specific, radiohalogenated nitroaromatic imaging probes.
    Kumar P; Bacchu V; Wiebe LI
    Semin Nucl Med; 2015 Mar; 45(2):122-35. PubMed ID: 25704385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment.
    Krishnamachary B; Mironchik Y; Jacob D; Goggins E; Kakkad S; Ofori F; Dore-Savard L; Bharti SK; Wildes F; Penet MF; Black ME; Bhujwalla ZM
    Neoplasia; 2020 Dec; 22(12):679-688. PubMed ID: 33142234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between HIFs and tumor immune checkpoints: mechanism and therapy.
    Liu J; Jiang Y; Chen L; Qian Z; Zhang Y
    Discov Oncol; 2024 Jan; 15(1):2. PubMed ID: 38165484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.